AbbVie is a global, research-based biopharmaceutical company. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
Type
Public
HQ
North Chicago, US
Founded
2013
Size (employees)
28,000 (est)+40%
Website
abbvie.com
AbbVie was founded in 2013 and is headquartered in North Chicago, US

Key People at AbbVie

Richard A. Gonzalez

Richard A. Gonzalez

Chairman of the Board and Chief Executive Officer

AbbVie Office Locations

AbbVie has an office in North Chicago
North Chicago, US (HQ)
1 Waukegan Rd

AbbVie Metrics

AbbVie Financial Metrics

Revenue (2016)

$25.6 b

Revenue growth (2015-16), %

12%

Gross profit

$19.8 b

Gross profit margin (2016), %

77%

Net income (2016)

$6 b

Market capitalization (21-Mar-2017)

$104.8 b

Closing share price (21-Mar-2017)

$65.8

Cash (31-Dec-2016)

$5.1 b
AbbVie's current market capitalization is $104.8 b.
AbbVie's revenue was reported to be $25.6 b in FY, 2016 which is a 12.2% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$18.8 b$20 b$22.9 b$25.6 b

Revenue growth, %

6%15%12%

Cost of goods sold

$4.6 b$4.4 b$4.5 b$5.8 b

Gross profit

$14.2 b$15.5 b$18.4 b$19.8 b

Gross profit Margin, %

76%78%80%77%

Operating expense total

$13.1 b$16.5 b$15.3 b$16.3 b

Interest expense

($278 m)($391 m)($686 m)($965 m)

Income tax expense

$1.2 b$595 m$1.5 b$1.9 b

Net Income

$4.1 b$1.8 b$5.1 b$6 b
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$9.6 b$8.3 b$8.4 b$5.1 b

Accounts Receivable

$3.9 b$3.7 b$4.7 b$4.8 b

Inventories

$1.2 b$1.1 b$1.7 b$1.4 b

Current Assets

$17.8 b$16.1 b$16.3 b$16.2 b

PP&E

$2.3 b$2.5 b$2.6 b$2.6 b

Goodwill

$6.3 b$5.9 b$13.2 b$15.4 b

Total Assets

$29.2 b$27.5 b$53.1 b$66.1 b

Total Debt

$3.9 b$4.3 b$29.6 b$36.8 b

Current Liabilities

$6.9 b$11.4 b$10.9 b$9.8 b

Additional Paid-in Capital

$3.7 b$4.2 b$13.1 b$13.7 b

Retained Earnings

$1.6 b$535 m$2.2 b$4.4 b

Total Equity

$4.5 b$1.7 b$3.9 b$4.6 b

Debt to Equity Ratio

0.9 x2.4 x7.5 x7.9 x

Debt to Assets Ratio

0.1 x0.2 x0.6 x0.6 x

Financial Leverage

6.5 x15.8 x13.4 x14.3 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$4.1 b$1.8 b$5.1 b$6 b

Accounts Receivable

$681 m($172 m)($1.1 b)($71 m)

Inventories

($56 m)($203 m)($434 m)($38 m)

Accounts Payable

($426 m)($193 m)$1.5 b($1.2 b)

Cash From Operating Activities

$6.3 b$3.5 b$7.5 b$7 b

Cash From Investing Activities

$879 m($926 m)($12.9 b)($6.1 b)

Short-term Borrowings

($601 m)$12 m($19 m)($29 m)

Dividends Paid

($2.6 b)($2.7 b)($3.3 b)($3.7 b)

Cash From Financing Activities

($3.4 b)($3.3 b)$5.8 b($3.9 b)

Income Taxes Paid

$1.3 b$498 m$1.1 b$3.6 b

AbbVie Market Value History

AbbVie Median Salaries

Source: 442 public H-1B filings from AbbVie

AbbVie Online Presence

AbbVie News

AbbVie Company Life

You may also be interested in